Sucampo Announces Second Quarter 2015 Earnings Call
22 juil. 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter 2015...
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference
01 juil. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 1, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)
15 juin 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the China Food and Drug Administration...
Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference
27 mai 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 27, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week
15 mai 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...
Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference
13 mai 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 13, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for AMITIZA(R) (lubiprostone) in China
11 mai 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that it entered into an exclusive license,...
FDA Grants Fast Track Designation to Sucampo's Cobiprostone for Oral Mucositis
07 mai 2015 16h42 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
Sucampo Reports First Quarter 2015 Financial Results and Corporate Update
06 mai 2015 06h30 HE
|
Sucampo Pharmaceuticals Inc
Strong Financial Performance Driven by Continued Revenue and Sales Growth of AMITIZA
Strong Growth in Net Income and EPS
Company Confirms 2015 Earnings Guidance
Company to Host Conference Call...
Sucampo Announces First Quarter 2015 Earnings Call
22 avr. 2015 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., April 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2015...